National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
Joel M. Gelfand, April W. Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna D. Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo Re, George M. Martin, Joseph F. Merola, José U. Scher, Sergio Schwartzman, James R. Treat, Abby S. Van Voorhees, Christoph T. Ellebrecht, Justine Fenner, Anthony J. Ocon, Maha N. Syed, Erica J. Weinstein, George Gondo, Sue Heydon, Samantha Koons, Christopher T. Ritchlin
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PsoriasisPandemicDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakTask forceVirologyDermatologyPathologyInfectious disease (medical specialty)OutbreakPublic administrationPolitical sciencePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsCOVID-19 and healthcare impacts